236 related articles for article (PubMed ID: 1373778)
1. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia.
Shapiro E; Becich MJ; Hartanto V; Lepor H
J Urol; 1992 May; 147(5):1293-7. PubMed ID: 1373778
[TBL] [Abstract][Full Text] [Related]
2. Autonomic receptors in human prostate adenomas.
Gup DI; Shapiro E; Baumann M; Lepor H
J Urol; 1990 Jan; 143(1):179-85. PubMed ID: 1688458
[TBL] [Abstract][Full Text] [Related]
3. Is one single prostate biopsy helpful for choosing a medical treatment of benign prostatic hyperplasia? A quantitative computerized morphometric study.
Zlota Ar; Sattar AA; Wespes E; Noel JC; Schulman CC
Urology; 1996 Mar; 47(3):329-34. PubMed ID: 8633397
[TBL] [Abstract][Full Text] [Related]
4. Morphometric analysis of symptomatic benign prostatic hyperplasia with and without bladder outlet obstruction.
Ichiyanagi O; Sasagawa I; Ishigooka M; Suzuki Y; Nakada T
Urol Res; 2000 Jan; 28(1):29-32. PubMed ID: 10732692
[TBL] [Abstract][Full Text] [Related]
5. Contractile properties of human prostate adenomas and the development of infravesical obstruction.
Gup DI; Shapiro E; Baumann M; Lepor H
Prostate; 1989; 15(2):105-14. PubMed ID: 2477832
[TBL] [Abstract][Full Text] [Related]
6. Percentage area density of epithelial and mesenchymal components in benign prostatic hyperplasia: comparison of results between single biopsy, multiple biopsies and multiple tissue specimens.
Robert M; Costa P; Bressolle F; Mottet N; Navratil H
Br J Urol; 1995 Mar; 75(3):317-24. PubMed ID: 7537601
[TBL] [Abstract][Full Text] [Related]
7. Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands.
Marks LS; Treiger B; Dorey FJ; Fu YS; deKernion JB
Urology; 1994 Oct; 44(4):486-92. PubMed ID: 7524234
[TBL] [Abstract][Full Text] [Related]
8. Relative proportions of tissue components in the prostate: are they related to the development of symptomatic BPH in Korean men?
Byun SS; Jeong H; Jo MK; Lee E
Urology; 2005 Sep; 66(3):593-6. PubMed ID: 16140084
[TBL] [Abstract][Full Text] [Related]
9. Morphometry of benign prostatic hyperplasia during androgen suppressive therapy. Relationships among epithelial content, PSA density, and clinical outcome.
Svindland A; Eri LM; Tveter KJ
Scand J Urol Nephrol Suppl; 1996; 179():113-7. PubMed ID: 8908676
[TBL] [Abstract][Full Text] [Related]
10. Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasia.
Cadeddu JA; Pearson JD; Lee BR; Landis P; Partin AW; Epstein JI; Carter HB
Urology; 1995 May; 45(5):795-800. PubMed ID: 7538241
[TBL] [Abstract][Full Text] [Related]
11. Correlation between morphometric differences and norepinephrine content in benign prostatic hyperplasia.
Ishigooka M; Hashimoto T; Hayami S; Suzuki Y; Sasagawa I; Nakada T
Prostate; 1996 Jun; 28(6):385-91. PubMed ID: 8650076
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
Matsuda T; Fujime M; Suda K
Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
[TBL] [Abstract][Full Text] [Related]
13. Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia?
Eri LM; Svindland A
Urology; 2000 Aug; 56(2):261-5. PubMed ID: 10925090
[TBL] [Abstract][Full Text] [Related]
14. Morphometric quantitation of stroma in human benign prostatic hyperplasia.
Deering RE; Bigler SA; King J; Choongkittaworn M; Aramburu E; Brawer MK
Urology; 1994 Jul; 44(1):64-70. PubMed ID: 7518983
[TBL] [Abstract][Full Text] [Related]
15. Relationship between urodynamic type of obstruction and histological component of the prostate in patients with benign prostatic hyperplasia.
Ichiyanagi O; Sasagawa I; Ishigooka M; Suzuki Y; Nakada T
Eur Urol; 1999 Sep; 36(3):203-6. PubMed ID: 10450003
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical localization of estrogen receptors in spontaneous and experimentally induced canine benign prostatic hyperplasia.
Schulze H; Barrack ER
Prostate; 1987; 11(2):145-62. PubMed ID: 2444954
[TBL] [Abstract][Full Text] [Related]
17. Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia.
Marks LS; Partin AW; Gormley GJ; Dorey FJ; Shery ED; Garris JB; Subong EN; Stoner E; deKernion JB
J Urol; 1997 Jun; 157(6):2171-8. PubMed ID: 9146609
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between the quantitative morphometry and the clinical response to alpha adrenergic blocker in benign prostatic hyperplasia].
Sakai S; Shimazaki J
Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):695-701. PubMed ID: 8709447
[TBL] [Abstract][Full Text] [Related]
19. Age-related changes of histological composition in established benign prostatic hyperplasia.
Ishigooka M; Hayami S; Suzuki Y; Hashimoto T; Sasagawa I; Nakada T
Eur Urol; 1996; 29(1):85-9. PubMed ID: 8821697
[TBL] [Abstract][Full Text] [Related]
20. Association of prostatic inflammation with down-regulation of macrophage inhibitory cytokine-1 gene in symptomatic benign prostatic hyperplasia.
Taoka R; Tsukuda F; Ishikawa M; Haba R; Kakehi Y
J Urol; 2004 Jun; 171(6 Pt 1):2330-5. PubMed ID: 15126815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
